KOPRAN
Back to All Ratios
|
KOPRAN Last 5 Year EV/CE History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
EV/CE(x) | 2.25 | 1.16 | 2.25 | 1.17 | 0.52 |
What is the latest EV/CE ratio of KOPRAN ?
Year | EV/CE |
---|---|
Mar2024 | 2.25 |
Mar2023 | 1.16 |
Mar2022 | 2.25 |
Mar2021 | 1.17 |
Mar2020 | 0.52 |
How is EV/CE of KOPRAN Trending?
Years | EV/CE | % Change | |
---|---|---|---|
Mar2024 | 2.25 | 93.97 | |
Mar2023 | 1.16 | -48.44 | |
Mar2022 | 2.25 | 92.31 | |
Mar2021 | 1.17 | 125.00 | |
Mar2020 | 0.52 | - |
Other Financial Ratios of KOPRAN
Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare EV/CE ratio of peers of KOPRAN
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
KOPRAN | ₹772.3 Cr | NA | -9.8% | -35.7% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹389,172.0 Cr | -1.2% | -3.6% | -8.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹158,248.0 Cr | -6.6% | -12.4% | 22.3% | Stock Analytics | |
CIPLA | ₹122,835.0 Cr | 0.3% | 1.2% | -5.3% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹122,793.0 Cr | 0.7% | 9.1% | 7.2% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹101,869.0 Cr | 0.4% | -2.8% | -12.7% | Stock Analytics |
KOPRAN Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
KOPRAN | NA |
-9.8% |
-35.7% |
SENSEX | -0.6% |
-2.8% |
1.7% |
You may also like the below Video Courses